Macquarie Group
STJ

Macquarie Group’s St Jude Medical STJ Stock Holding History

Macquarie Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-64,356
Closed -$5.16M – 1606
2016
Q4 		$5.16M Sell
64,356
-33,672
-34% -$2.67M 0.01% 732
2016
Q3 		$7.82M Sell
98,028
-88,214
-47% -$7.12M 0.02% 657
2016
Q2 		$14.5M Buy
186,242
+103,061
+124% +$7.35M 0.01% 636
2016
Q1 		$4.58M Buy
83,181
+931
+1% +$50.7K 0.01% 725
2015
Q4 		$5.08M Buy
82,250
+1,761
+2% +$111K 0.01% 701
2015
Q3 		$5.08M Buy
80,489
+1,309
+2% +$93.4K 0.01% 702
2015
Q2 		$5.79M Sell
79,180
-23,857
-23% -$1.72M 0.01% 708
2015
Q1 		$6.74M Sell
103,037
-57,800
-36% -$3.84M 0.01% 661
2014
Q4 		$10.5M Sell
160,837
-3,329
-2% -$214K 0.02% 511
2014
Q3 		$9.87M Sell
164,166
-12,892
-7% -$842K 0.02% 506
2014
Q2 		$12.3M Buy
177,058
+35,088
+25% +$2.27M 0.03% 467
2014
Q1 		$9.28M Buy
141,970
+2,070
+1% +$135K 0.02% 514
2013
Q4 		$8.67M Buy
139,900
+50,840
+57% +$2.94M 0.02% 504
2013
Q3 		$4.78M Sell
89,060
-101,811
-53% -$5.24M 0.01% 629
2013
Q2 		$8.71M Buy
+190,871
New +$8.27M 0.02% 473

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Macquarie Group's STJ Position: Q1 2017 in Review

Macquarie Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 64,356 shares — an estimated $5.16M sold.

Macquarie Group first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $14.5M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Macquarie Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Macquarie Group sold 64,356 St Jude Medical shares in Q1 2017, an estimated $5.16M.
  • Macquarie Group first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Macquarie Group's St Jude Medical position peaked at $14.5M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Macquarie Group's 13F filing for Q1 2017, filed 16 May 2017.